Trial
NCT03274778
Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Oncology Institute of Southern Switzerland
Collaborators
—
Condition
Prostate Cancer
Intervention
Ruxolitinib 20 MG
Why stopped
Recruitment difficulty due to eligibility criteria.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-18